(Q38160090)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ana Luisa Teixeira

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Juliana I Santos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Mónica Gomes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Augusto Nogueira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Rui Medeiros

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Joana Assis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1793-1803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

The epidemiology of renal cell carcinoma.

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

EAU guidelines on renal cell carcinoma: the 2010 update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNAs and their target gene networks in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

von Hippel-Lindau syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

The von Hippel-Lindau tumor suppressor gene and kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

The von Hippel-Lindau tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Clinical implications of hypoxia inducible factor in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Prognostic factors for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Signaling through the epidermal growth factor receptor during the development of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Regulation of endocytosis via the oxygen-sensing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Update on the medical treatment of metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

DNA methylation and microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Delivering the promise of miRNA cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Comprehensive molecular characterization of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

OncomiRs: the discovery and progress of microRNAs in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNA-21: a novel therapeutic target in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Identification of a microRNA panel for clear-cell kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNA-210: a unique and pleiotropic hypoxamir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Potential biofluid markers and treatment targets for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Accurate molecular classification of kidney cancer subtypes using microRNA signature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Role of miR-10b in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

miR-221 silencing blocks hepatocellular carcinoma and promotes survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.184

21 January 2018

Identifiers

DOI

10.2217/PGS.13.184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192126%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference